PureTech Health PLC Notice of Results (1446P)
February 16 2016 - 4:00AM
UK Regulatory
TIDMPRTC
RNS Number : 1446P
PureTech Health PLC
16 February 2016
PureTech Health - Notice of results
Boston, Massachusetts, February 16, 2016 - PureTech Health plc
("PureTech" or the "Company", LSE: PRTC), a cross-disciplinary
healthcare company developing novel medicines to tackle fundamental
healthcare needs in disruptive ways, plans to announce its
financial results for the year ended 31 December 2015 on Thursday 7
April 2016.
As previously announced PureTech will also hold its first
Capital Markets Meeting in London on Tuesday 10 May 2016 from
13.00-17.00 BST. The meeting will feature PureTech presenters
including members of the Company's Board of Directors and
management from the Company's operating business units. Please
confirm if you would like to attend the Capital Markets Meeting to
PureTech.Event@fticonsulting.com
About PureTech Health
PureTech Health (PureTech Health plc, PRTC.L) is a
cross-disciplinary healthcare company, developing innovative
products that could improve the lives of billions of patients.
PureTech has a pipeline of 12 operating companies, seven of which
are "growth stage" with external validation including strategic
partnerships, outside funding, proof-of-concept or peer review in
prestigious scientific journals. PureTech also has a pipeline of
ten "concept phase" initiatives resulting from review of more than
650 ideas annually. PureTech is focused on areas including immune
and inflammatory disorders; cognitive and psychiatric disorders;
diabetes and obesity; oncology; and infectious diseases, and has
over 110 patents and patent applications. PureTech's leading team
and board, along with an advisory network of more than 50 expert
founder-scientists and advisors across multiple disciplines, gives
PureTech access to potentially ground-breaking science and
technological innovation. For more information, visit
www.puretechhealth.com and connect with us on Twitter.
# # #
Enquiries:
PureTech
Stephen Muniz, Executive Vice President, +1 617 456
Legal, Finance and Operations 0042
FTI Consulting (Communications adviser
to PureTech)
Ben Atwell +44 (0) 20
Matthew Cole 3727 1000
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORDXGDDRUBBGLU
(END) Dow Jones Newswires
February 16, 2016 04:00 ET (09:00 GMT)
Puretech Health (LSE:PRTC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Puretech Health (LSE:PRTC)
Historical Stock Chart
From Jul 2023 to Jul 2024